CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-05 | JUNIUS DANIEL M Director | Option exercise | +3,046 | $160.28 | $488K | 6,014 |
| 2022-12-05 | JUNIUS DANIEL M Director | Sale | −3,046 | $424.91 | $1.3M | 2,968 |
| 2022-12-05 | JUNIUS DANIEL M Director | Option exercise · Non-Qualified Stock Option (right-to-buy) | −3,046 | 0 | ||
| 2022-12-02 | SZOSTAK M ANNE Director | Option exercise | +2,000 | $160.28 | $321K | 2,000 |
| 2022-12-02 | SZOSTAK M ANNE Director | Sale | −740 | $428.55 | $317K | 1,260 |
| 2022-12-02 | SZOSTAK M ANNE Director | Option exercise · Non-Qualified Stock Option (right-to-buy) | −2,000 | 1,046 | ||
| 2022-12-01 | Turner Kathy V Senior Vice President | Option exercise | +3,000 | $141.60 | $425K | 9,923.39 |
| 2022-12-01 | Turner Kathy V Senior Vice President | Sale | −3,000 | $436.00 | $1.3M | 6,923.39 |
| 2022-12-01 | Turner Kathy V Senior Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −3,000 | 7,386 | ||
| 2022-11-14 | MAZELSKY JONATHAN JAY President & CEO | Option exercise | +18,998 | $62.00 | $1.2M | 81,304.64 |
| 2022-11-14 | MAZELSKY JONATHAN JAY President & CEO | Sale | −972 | $433.37 | $421K | 80,332.64 |
| 2022-11-14 | MAZELSKY JONATHAN JAY President & CEO | Sale | −6,385 | $434.26 | $2.8M | 73,947.64 |
| 2022-11-14 | MAZELSKY JONATHAN JAY President & CEO | Sale | −2,543 | $435.07 | $1.1M | 71,404.64 |
| 2022-11-14 | MAZELSKY JONATHAN JAY President & CEO | Sale | −600 | $435.88 | $262K | 70,804.64 |
| 2022-11-14 | MAZELSKY JONATHAN JAY President & CEO | Option exercise · Non-Qualified Stock Option (right-to-buy) | −18,998 | 0 | ||
| 2022-11-09 | AYERS JONATHAN W Director | Gift | −5,000 | 170,420 |
Page 52 of 52 · 1,036 trades